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Summary Recently published results of epidemiologic case-control studies in China and Italy on gastric
carcinoma in relation to diet suggest that consuming garlic may reduce the risk of gastric cancer. Chemical
constituents of garlic have been tested for their inhibiting effect on carcinogenesis, using in vitro and in vivo
models. In most experiments inhibition of tumour growth was established using fresh garlic extract, garlic
compounds or synthetically prepared analogs. In this review the strengths and weaknesses of the experiments
are discussed and the outcomes are evaluated to assess the possible significance of garlic or garlic compounds
for the prevention of cancer in humans. It is concluded that evidence from laboratory experiments and
epidemiologic studies is presently not conclusive as to the preventive activity of garlic. However, the available
evidence warrants further research into the possible role of garlic in the prevention of cancer in humans.
Elimination of carcinogenic substances from the environment
is the preferable method to prevent malignant tumour
development. However, contact with carcinogenic substances
is not always avoidable (Wattenberg, 1985; Weinstein, 1981).
Therefore, chemoprevention, in which the occurrence of
cancer is prevented by administration of inhibitory com-
pounds, has received increased attention (Malone, 1989; Wat-
tenberg, 1985).
The relation between the use of allium vegetables,
especially garlic (Allium sativum, a member of the genus
Allium to which some 500 species belong), and its con-
stituents, and the occurrence of cancer in humans is of
particular interest in this respect. In a number of reviews on
the effects of garlic on health, possible preventive effects on
the development of cancer in humans have been mentioned.
Fenwick and Hanley (1985) reviewed experimental studies
designed to demonstrate any anticancer activity of garlic,
together with the results of an epidemiological study in China
in which death rates between two adjacent provinces were
compared. In the latter study the highest gastric death rate
had been found in the province with the lowest intake. The
possible anticancer activity of garlic was illustrated in an
earlier review of two studies reporting the inhibition of trans-
planted tumours in mice (Bolton et al., 1982). In a publica-
tion on new dietary anticarcinogens and the prevention of
gastrointestinal cancer, diallylsulfide, a component of garlic,
was identified as a suppressing agent in dimethylhydrazine
(DMH)-induced colon and nitrosomethylbenzylamine
(NMBA)-induced oesophageal cancer development in rats
(Wargovich, 1988). Suggested inhibitory mechanisms were
evaluated in a review of selected recent publications on the
effects ofgarlic on tumour formation in experimental animals
(Sumiyoshi & Wargovich, 1989). In an earlier review free
radical scavenging activity, immune system modulation and
direct cytotoxic effect on cancer cells were discussed (Abdul-
lah et al., 1988). More recently the possible effects of garlic
on detoxification systems in vivo and in vitro were reviewed
(Dausch & Nixon, 1990). The changing patterns of cancer in
the United States, United Kingdom and the Federal Republic
of Germany led to speculations on the role of synthetic and
natural carcinogens and anticarcinogens. Compounds of gar-
lic were mentioned as inhibitors of tumour promotion
(Davis, 1989). Based on the results from experimental and
epidemiologic studies, Lau et al. (1990) concluded that garlic
may be categorised as a dietary anticarcinogen.
Several investigators proposed a categorisation of sub-
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stances with possible anticarcinogenic activity based on the
steps in chemical induction ofneoplasia (Bertram et al., 1987;
Malone, 1989; Wattenberg, 1985; 1990). In contrast with
earlier reviews, we have ordered the in vitro and in vivo
screening tests on the possible anticarcinogenic effects of
garlic and garlic constituents according to this categorisation.
Strengths and weaknesses of the experiments are discussed
and whether their results provide any basis for the suggestion
that garlic can prevent the development of cancer in humans.
Methods
Publications on garlic or garlic compounds and the relation
with cancer, carcinogenicity or anticarcinogenicity were
found by searching MEDLINE, a computer service available
on CD-ROM (1983-1991) and by checking references to find
earlier reports.
After a short overview of the chemical composition and
active compounds of garlic, studies are reviewed on garlic
preparations or specific chemical compounds possibly related
to the proposed antitumour effect. According to the com-
ponents of a sequential staging in preclinical research on
chemopreventive agents (Malone, 1989), in vitro experiments
on the identification of promising compounds are reviewed
first. Next, in vivo screening tests involving animal models to
evaluate the efficacy of compounds against carcinogenic
agents at specific target sites, are reviewed.
Studies employing models in which malignant tumours are
transplanted into experimental animals or models using spon-
taneous tumour formation are not reviewed, because these
models are not considered relevant for research on cancer
prevention (Malone, 1989).
Finally, the results of epidemiological studies in human
populations are summarised and suggestions for further
research are given.
Chemical composition and active compounds ofgarlic
The main components of fresh garlic are water, carbohy-
drates, protein, fibre and fat. Garlic contains essential amino
acids, vitamins and minerals. Garlic oil obtained by steam
distillation, dehydrated garlic powder, pickled garlic, garlic
juice and garlic extracts are available as condiments or nutri-
tional supplements (Raghavan et al., 1983). 'Aged garlic
extract', a special garlic preparation, is obtained by extrac-
ting sliced raw garlic in a low concentration of ethanol at
room temperature over a long period of time (Hirao et al.,
1987).
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The reported medicinal effects are ascribed to oil- and
water-soluble organosulfur compounds, also responsible for
the flavour and odour of garlic (Block, 1985; Dubick, 1986;
Fenwick, 1985; Sumiyoshi & Wargovich, 1990). Chemical
structures of compounds reported in this review, including
the abbreviations used in the text, are presented in Table I.
One of the organosulfur compounds, the odourless amino
acid alliin, is enzymatically converted into allicin when the
garlic cloves are crushed. Allicin is accountable for the char-
acteristic odour of fresh garlic and has antibacterial proper-
ties (Cavallito & Bailey, 1944). In a study ofWills (1956), the
selective inactivation of SH-enzymes could be attributed to
the presence of the -S-SO- bond in allicin. Since this inactiva-
tion might be of importance in relation to inhibition of
malignant tumour growth, Weisberger and Pensky (1957)
initiated studies of compounds related to allicin. A progres-
sive decrease in uptake of "5S in leukaemic leukocytes, sup-
posedly related to -SH inactivation, was observed in an
experiment on the effect of a diethyl analog of allicin, ethyl-
thiosulphinic ethyl ester. The -S-SO-bond in other allicin-like
substances and the ability to react with -SH groups was
thought to be essential for tumour formation inhibition
(Weisberger & Pensky, 1958).
Allicin, however, is unstable and converts readily into
mono-, di-, tri- and polysulfides, sulfur oxide and other
compounds such as ajoene (Block, 1985; Raghavan et al.,
1983). An extensive overview of the chemistry of the
organosulfur compounds in both intact and crushed garlic is
published by Whitaker (1976).
Allixin, a so-called phytoalexin or 'stress compound', is a
phenolic compound synthesised by garlic (Yamasaki et al.,
1991).
Identification of possible chemopreventive compound through in
vitro techniques
The first stage in preclinical research on chemopreventive
agents, as in drugs screening, is the identification of promis-
ing compounds through in vitro screening systems (Malone,
1989). A large variety of garlic compounds has been inves-
tigated in models using chemical carcinogens (initiators and
promoters) or radiation. Extracts of garlic and fractions
isolated from it, as well as specific chemical compounds, both
naturally derived or synthetically made, were identified as
possible chemopreventive agents.
Ajoene, DAS, allixin and crude garlic extract exhibited a
dose-dependent inhibition ofAFB,-mutagenesis, inhibition of
DNA binding and adduct formation, as well as inhibition of
the formation of AFB1-metabolites (Tadi et al., 1991;
Yamasaki et al., 1991). Crude aqueous garlic extract demon-
strated antimutagenic activity against y-radiation, peroxides,
doxorubicin and MNNG. No effect was detected against
several other mutagens. A dose-dependent decrease of H202-
induced lipid peroxidation suggested radical-scavenging
activity. Of the purified compounds allicin, alliin and cysteine
only allicin showed inhibition of y-radiation-induced
mutagenesis (Knasmuller et al., 1989).
DAS reduced the macromolecular binding of DMH in
hepatocytes, while levels of GST, glutathione reductase or
glutathione peroxidase were not influenced (Hayes et al.,
1987). Garlic oil inhibited both the prolonged decrease in
activity of the glutathione-dependent antioxidant protective
system and the induction of ODC activity (an enzyme impor-
tant in the regulation of DNA synthesis and involved in the
early phase of the second stage of tumour promotion) caused
by TPA and other promoters. The effect was time and dose-
dependent. Onion oil and dipropenylsulfide were less effective
(Perchellet et al., 1986). Both ethanolic garlic extract and
allixin inhibited 32P-incorporation into cell phospholipids in
the early phase of TPA-induced tumour promotion in a
dose-dependent manner (Nishino et al., 1989; Nishino et al.,
1990). Tests on the stimulating effect on macrophage activity
againt heterogenous tumour cells revealed that a high
molecular fraction isolated from aged garlic extract was more
effective than aged garlic extract itself and other, low
molecular, compounds like allicin, DADS and AMT. Mitotic
activity of spleen cells was enhanced by preculturing the cells
with the high-molecular fraction (Hirao et al., 1987).
In one study the effect of garlic oil was not published,
because the cell morphology was drastically altered at the
concentration used (Zelikoff, 1985). In another study it was
Table I Compounds in garlic and garlic products tested by in vitro and in vivo assays for possible anticarcinogenic activity
Chemical structure Compound abbrev.
CH2=CH-CH2-S (O)-CH2-CH (NH2)-COOH
CH2=CH-CH2-S(O)-S-CH2-CH=CH2
CH2=CH-CH2-S(O)-CH2-CH=CH-S-S-CH2-CH=CH2
CH2=CH-CH2-S-CH2-CH=CH2
CH2=CH-CH2-S-S-CH2-CH=CH2
CH2=CH-CH2-S-S-S-CH2-CH=CH2
CH2=CH-CH2-S-S-CH3
CH2=CH-CH2-S-S-S-CH3
CH2=CH-CH2-SH
CH2=CH-CH2-S-CH2-CH (NH2)-COOH
0
H3CO OH
H3C \o/L CH2CH2CH2CH2CH3
alliin
allicin
ajoene
diallylsulfide
diallyldisulfide
diallyltrisulfide
allylmethyldisulfide
allylmethyltrisulfide
allylmercaptan
S-allylcysteine
allixin
DAS
DADS
DAT
AMD
AMT
AM
SAC
I426 E. DORANT et al.
suggested that both garlic oil and onion oil act as promoting
agents. Enhancement of NIH-3T3 cells proliferation was seen
subsequent to treatment with either oil at nontoxic levels, but
in combination with the tumour promoter PMA the growth
stimulating activity was inhibited (Zelikoff et al., 1984).
Some studies focus on showing antimitotic activity in cul-
tured cells. The effects demonstrated with ethanolic and
aqueous extract of dried powdered garlic depended on the
test cells used. Ethanolic extract exhibited a stronger effect
than aqueous extract. But, although inhibition of DNA-
synthesis could be established, the concentrations needed
were higher than the concentrations required to affect cell
viability (Unnikrishman & Kuttan, 1988). Ajoene exerted a
stronger effect on the viability of tumourigenic cells than of
non-tumourigenic cells. The effect depended on the amount
ofajoene per cell, the protein content of the cell and duration
of treatment. Ajoene was twice as active as allicin and
seemed to act immediately after its uptake (Scharfenberg et
al., 1990). In a test with raw garlic juice a dose-dependent
inhibition of mitosis was observed, with sticking and clotting
of chromosomes (Konvicka, 1984).
In vivo assays evaluating the efficacy ofgarlic and garlic
compounds against carcinogenic agents at specific target sites
Any anticarcinogenic agent identified by in vitro screening
should be further evaluated by in vivo screening (Malone,
1989).
According to the opportunities for chemical intervention
proposed by Wattenberg (1985 & 1990), Malone (1989) and
Bertam (1987), we have ordered those animal experiments in
which the effect of the potentially chemopreventive com-
pounds from garlic on carcinogenic mechanisms have been
studied, into those dealing with initiation and those dealing
with promotion.
Initiation
Initiation might be inhibited by preventing the formation of
carcinogens from precursors, blocking the metabolic activa-
tion of carcinogens, increasing the detoxification of car-
cinogens by increasing the level of the enzymes involved (e.g.
glutathione S-transferase), interception of carcinogens prior
to their reaction with DNA, stimulation of error-free DNA
repair or suppression of cell proliferation (Malone, 1989;
Wattenberg, 1985; 1990).
However, although many tests on inhibition of initiation
have been performed, the results are not conclusive yet and
the mechanisms of action still remain unclear. AMT (with
doses ranging from 0.003-0.024 mmol p.o.) showed an
inhibitory effect on the number and malignancy of BaP-
induced forestomach tumours in mice, whereas no effect on
tumour development in the lung could be detected. However,
a dose-dependent enhancement of GST activity was observed
in the forestomach and in the lung, as well as in the liver and
small intestines (Sparnins et al., 1986; Sparnins et al., 1988).
DAT (0.02 mmol p.o.) and AMD (0.01-0.04 mmol p.o.)
inhibited tumour development in both forestomach and lung
and also induced an increase in GST activity. DAS
(0.02 mmol p.o.) had little effect on forestomach tumour
development, but stimulated GST activity in this organ,
whereas inhibition of lung tumour development was found
without an increase of GST activity. Saturated analogs of the
garlic compounds showed almost no activity (Sparnins et al.,
1988). DAS (0.02 mmol p.o.) was less effective in inhibiting
the NDEA-induced development of forestomach papillomas and carcinomas when compared with DADS (0.2 mmol p.o.), AM (0.01 mmol p.o.) and AMD (0.02 mmol p.o.). All four
garlic compounds showed little inhibition of pulmonary neoplasm development. The inhibitory capacities depended
on the number of allyl groups and fluctuated with varying times of administration (Wattenberg et al., 1989). The
observed difference between several oil- and water-soluble
garlic compounds in stimulating GST activity in colon and
liver also depended on the presence of allyl groups
(Sumiyoshi & Wargovich, 1990). DAS (200 mg kg-' p.o.)
could not inactivate the direct acting carcinogens MNU and
MNNG in mice, whereas a strong, dose-dependent, inhibi-
tion of the procarcinogen DMH, requiring metabolic activa-
tion, was observed in mice as well as in rats (Hayes et al.,
1987; Wargovich & Goldberg, 1985). Because DAS (200 mg
kg-' p.o.) did not induce GST or DT-diaphorase in the liver
of mice, it was suggested that DAS induces alterations in
hepatic mixed function oxidase activity leading to
modification ofcarcinogen metabolism (Wargovich, 1987). In
another study DAS (200 mg kg-' i.g.) was found to be a
time-dependent competitive inhibitor of NMBA- and
DMNA-induced hepatic microsomal monooxygenase activity
in rats, probably by selective inhibition of the cytochrome
P450 isozymes active in the oxidative metabolism of various
carcinogenic compounds (Brady et al., 1988). Orally (200 mg
kg-') or topically administered DAS prevented the induction
of nuclear aberrations in hair follicle cells and in the bladder
induced by cyclophosphamide, either by mitotic inhibition of
target cells or a diversion of excretion of cyclophosphamide
from urine to faeces (Goldberg & Josephy, 1987).
In rats, y-radiation-induced ODC activity and DNA syn-
thesis in colon mucosa cells was partially suppressed by DAS
(50-400 mg kg-' p.o.). But, because the y-radiation-induced
nuclear aberration formation was not decreased by DAS
(200 mg kg-' p.o.) in the presence of an ODC inhibitor, the
investigators suggested that DAS stimulates the DNA repair
process (Baer & Wargovich, 1989). DAS (50-400mgkg-'
p.o. or i.p.) also suppressed ODC activity and nuclear aber-
ration formation in the stomach after induction with MNNG
(Hu & Wargovich, 1989), reduced NMBA-induced nuclear
aberration formation and the conversion of NMBA by
hepatic microsomes. Oesophageal cancer development was
completely inhibited, although no direct effect on
oesophageal microsome activity was observed (Wargovich et
al., 1988). Oral treatment with fresh garlic (400 mgkg-')
significantly reduced the percentage of mice with MC-induc-
ed tumours of the uterine cervix (Hussain et al., 1990).
Topically applied garlic oil in the initiating phase of BaP-
induced skin carcinogenesis decreased the number of mice
with skin tumours and the mean number of tumours per
mouse (Sadhana et al., 1988). In one report the anticar-
cinogenic properties of fresh ground garlic were compared
with the activity of the carcinogens BaP and NTP. It is
therefore not surprising that the mean tumour number in the
garlic group was significantly lower than in the other groups
(Shyu & Meng, 1987).
Promotion
Two-stage skin carcinogenesis models have been used to
separately test inhibition of tumour promotion by garlic
extract or compounds. Low doses of topically applied garlic
oil inhibited tumour formation induced by DMBA and
PMA, but theeffect was generally less than with onion oil
(Belman, 1983). Fresh garlic extract reduced the percentage
of mice with skin papillomas and the mean number of papil-
lomas per tumour-bearing mouse. Inhibition of DMBA-
induced malignant carcinoma development was also observed
by other investigators (Rao et al., 1990; Unnikrishman &
Kuttan, 1990). Garlic extract completely inhibited skin
tumour formation induced by the first stage promoter TPA,
while less inhibition was observed with the second stage
promoter mezerein (Nishino et al., 1989). Treatment with
1 mg allixin simultaneously with TPA resulted in a significant
inhibition of tumour development (Nishino et al., 1990).
Toxicity
An important element in the evaluation of the possible role
of chemopreventive compounds is the assessment of pre-
clinical toxicity (Malone, 1989). In most of the in vivo
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been studied, although one fresh garlic clove contains only a
very small amount of this specific chemical compound: less
than 1 mg (Wargovich, 1987). Conversion and extrapolation
of the effective doses used in these tests would lead to
unrealistic quantities of fresh garlic humans should use to
exhibit similar effects on carcinogenesis: 25-400 garlic cloves
per kg body weight.
In humans the consumption of small amounts of raw
garlic may already lead to toxic effects. Garlic, raw or
cooked, infused into the stomachs of healthy volunteers on
separate days induced a significant mean increase in DNA
content of gastric aspirates with a dose of 0.75 g or more,
indicating damage of the gastric mucosa (Desai et al., 1990).
However, no important negative side effects were reported in
a human experiment investigating the effect on natural killer
cell activity of eating raw garlic (0.5 gkg-' daily) or taking
garlic capsules (dose 1800mg daily) for 3 weeks (Kandil et
al., 1987).
The toxicity ofgarlic oil and of fresh garlic extract has also
been studied in rats and mice. Albino rats fed garlic oil
intragastrically (100mgkg-') after a period of fasting, died
within a few hours from pulmonary oedema. Rats fed with
fresh raw garlic extract (200gl-' drinking water) exhibited
non-specific liver injury. Combining normal diet with intra-
gastrically feeding of garlic oil (100mgkg-') did not elicit
toxic effects (Joseph et al., 1989). On the other hand, in one
of the aforementioned studies no toxic effects were observed
after oral administration of fresh ground garlic (400 mg kg-')
(Hussain et al., 1990). In the study by Belman all mice died
after a single application of 10 mg garlic oil on the skin
(Belman, 1983).
Epidemiologic research
Very few epidemiologic studies have been carried out on the
possible preventive activity ofgarlic on tumour development.
In 1988, You et al. reported the results of a population-based
case-control study in China on the relation between diet and
gastric carcinoma. A structured questionnaire was used in
1984 by trained interviewers to assess the usual frequency of
intake and portion size of foods and beverages in 1980
(approximately 4 years before the diagnosis) as well as prior
to the Cultural Revolution in 1965. Cases and controls were
grouped into tertiles or quartiles of intake, based on their
annual consumption ofspecific or total allium vegetables. An
inverse trend with increased total allium intake was found
which persisted after adjustment for intake of other fresh
vegetables. The odds ratio of the highest quartile of con-
sumption of alliums (>24.0 kg yr or >65 g/day) compared
to the lowest quartile ( = <11.5kg/yr or = <32 g/day) was
0.4 (95% CI0.3-0.6). Analysis of the effect of specific allium
vegetables (garlic, garlic stalks, scallions, Chinese chives and
onions) showed a protective effect of each allium vegetable.
Comparing the highest tertile of garlic intake ( = < 1.5 kg/
year or = >2 cloves per day) with the nonusers resulted in
an odds ratio of 0.7 (95% CI0.4-1.0) when adjusted for sex,
age, family income and intake of other alliums. The highest intake ofchinese chives (> 3.7 kg/yr) compared to the lowest
intake (< 1.5 kg/yr) was associated with the lowest odds
ratio compared with other allium vegetables (OR = 0.6
adjusted for sex, age, family income and intake of other
alliums, 95% CI 0.4-0.8). These associations were unlikely
to be related to changes in the diet because no differences in
consumption pattern for allium could be found between
intake in 1980 and in 1965. However, 50% of the carcinomas
were not histopathologically confirmed: 32% were based on
surgical or endoscopic information and 17% on radiological
or clinical examination (You et al., 1988; You et al., 1989). In a case-control study conducted in Italy, the role of
dietary factors associated with the regional variation in gas- tric carcinoma has been investigated. Patients with histo-
pathologically confirmed epithelial gastric carcinoma, and
controls, randomly selected from the general population with
the same age and sex distribution, were interviewed. A struc-
tured questionnaire was used to assess the usual frequency of
intake and portion size of food and beverages consumed
during a 1-year period 2 years prior to the interview. Intake
was categorised into tertiles defined by weekly frequency of
consumption among controls. A significant trend of decreas-
ing risk of gastric carcinoma was observed with increasing
frequency of intake of condiments containing garlic and
onions, when adjusted for age, sex, study area, social class,
residence, migration from the south, family history of gastric
cancer and Quetelet Index. Aware of the results of the
Chinese case-control study, the Italian investigators included
during the study a question on the frequency ofintake of raw
or cooked garlic. A significantly decreased risk was observed
with increasing frequency of comsumption of cooked garlic
by the 27% of the participants who were asked this question
(n = 275), with persons in the highest tertile of intake having
40% of the risk compared to those in the lowest tertile. The
consumption of raw garlic was too low for evaluation
(Buiatti et al., 1989).
Discussion
Among the medicinal effects of garlic, a widely used food
item worldwide, is its suggested inhibitory activity on malig-
nant tumour growth.
To evaluate the magnitude of the antitumour effects and to
assess its relevance for the prevention of cancer in humans,
we have reviewed publications on the relation between garlic
or garlic constituents and anticarcinogenic activity or inhibi-
tion of the development of malignant tumours.
Although not all publications on in vitro screening tests did
report a positive effect of garlic compounds on anticar-
cinogenic mechanisms, most of the outcomes support the
hypothesis that garlic or specific garlic compounds have at
least antimutagenic properties. According to the sequential
staging in chemoprevention and pharmaceutical research,
these compounds (DAS, ajoene, allixin, allicin, garlic oil,
fresh and aged garlic extract and high molecular fractions.
prepared from aged garlic extract) are eligible for further
investigation.
Many in vivo experiments, using initiation-promotion
models and chemical induction, were performed to assess the
anticarcinogenic activity of promising compounds, and of
compounds not yet tested by in vitro experiments. However,
definite conclusions cannot be drawn.
The allyl (CH2 = CHCH2 -)containing compounds DAS,
DADS, DAT, AM, AMD, AMT, SAC and fresh garlic
extract inhibited the formation ofmalignant tumours induced
by various initiators, although the mechanisms of action are
not evident. In many studies organ-specific (Sparnins et al.,
1988), and dose- and time-dependent (Sparnins et al., 1986;
Sumiyoshi & Wargovich, 1990) enhancement of GST activity
could be detected. However, some investigators concluded
that the observed tumour inhibition cannot simply be a
consequence of this enhancement (Hayes et al., 1987; Spar-
nins et al., 1988; Sumiyoshi & Wargovich, 1990; Wargovich,
1987). Furthermore, selective inhibition of hepatic procar-
cinogen (NMBA, DMNA) activation was measured (Brady
et al., 1988), suppression of MNNG-induced or y-radiation-
induced ODC activation in stomach and colon (Baer &
Wargovich, 1989; Hu & Wargovich, 1989), and suppression
of y-radiation-induced DNA synthesis in the colon (Baer &
Wargovish, 1989).
DAS, which did not inactivate direct acting carcinogens in
mouse colonic mucosa (Wargovich & Goldberg, 1985), but
produced a marked inhibition in the stomach of rats using a
similar dose and route of administration (Hu & Wargovich,
1989), might exhibit different results dependent on the species
or animal strain studied.
Inhibition of tumour promotion has the greatest potential
for human intervention, because the promotion phase takes a
long time, promoters act less specifically compared with
initiators and repeated exposures are needed to induce per-
manent alterations (Malone, 1989; Wattenberg, 1985). How-428 E. DORANT et al.
ever, only a few studies have been performed to establish the
effect of garlic in the promotion phase. All studies employed
the mouse skin carcinogenesis model initiated with DMBA
and promoted with PMA, TPA or mezerein. Garlic oil, garlic
extracts and allixin reduced the percentage of mice with skin
tumours as well as the mean number of tumours per tumour-
bearing mouse. Antipromoting activity of other garlic com-
pounds has not yet been investigated.
Safety and toxicity of the possible anticarcinogenic com-
pounds also deserve more attention. Conversion of the doses
of pure chemicals tested in animals to their equivalent in
terms of fresh garlic cloves and extrapolation of the effective
doses to humans will lead to unrealistic amounts of garlic
having to be consumed in order to profit from the described
antitumour effects, as is mentioned earlier.
Epidemiologic studies are required in which the prevention
of cancer in humans by garlic and related alliums is further
investigated. Although epidemiologic studies in China and
Italy suggest a decreasing risk for stomach cancer with in-
creasing consumption of garlic or related allium vegetables,
both the design of the studies, the ascertainment of the cases
and the measurement of the garlic intake, limit the possibility
of drawing definite conclusions. In the Chinease case-control
study only 50% of the gastric carcinoma cases were histo-
pathologically confirmed. It is not clear whether the other
cases did have gastric cancer or other gastric defects such as
ulcers. If garlic consumption differs between the two groups
inclusion of all cases in the analysis might give invalid
results.
In the Italian case-control study the frequency of garlic
consumption was assessed in 27% of the participants. A
decreasing risk with increasing level of consumption of
cooked garlic was reported. The results, however, cannot
easily be interpreted and compared with the reported effects
in China, because the actual levels of weekly consumption of
garlic were not given.
An important difficulty in investigating the relation
between the use of garlic and cancer development in humans
is the determination of the actual intake of possible preven-
tive compounds from garlic or garlic supplements. The
activity of garlic and garlic preparations is ascribed to com-
pounds containing allyl groups bonded to sulfur (Sumiyoshi
& Wargovish, 1990; Wattenberg et al., 1989). Recent research
on quantification of organsulfur compounds in fresh garlic
and commercially available garlic products revealed con-
siderable variation in the results. The highest total amount of
sulfur compounds was detected in steam-distilled garlic oils.
However, in only one of the 39 different preparations tested
was the total amount of organosulfur compounds per gram
product shown to be higher than in store-purchased garlic
cloves (Lawson et al., 1991).
In epidemiologic studies information on the timing of
exposure is crucial. If garlic has an inhibitory effect on
initiation, the garlic consumption should precede or accom-
pany the contact with the initiating agent. However, if garlic
inhibits promotion the relevant time period of garlic con-
sumption is closer to the moment of diagnosis. In the Italian
case-control study the habitual frequency or garlic consump-
tion 2 years before the interview was assessed. Thus, it was
implicitly assumed that the garlic intake 2 years prior to
diagnosis reflected the intake during either the initiation or
promotion phase of gastric carcinoma development. If pre-
clinical gastric cancer does not cause symptoms prior to this
two year interval, leading to avoidance of irritating foods
such as garlic, this assumption might be true. If not, the
results might have been biased.
A prospective study in which the dietary intake is assessed
before cancer develops, is a preferable method to study a
possible preventive effect of garlic on cancer development in
humans. In 1986 a large-scale prospective cohort study on
diet, life style factors, use of dietary supplements and the
occurrence of cancer was started in The Netherlands. The
cohort comprises 120.852 men and women, aged 55-69
years. At baseline, a questionnaire on dietary habits and
potential confounders was completed (Van den Brandt et al.,
1990). The analysis on the relation between garlic and cancer
development will be focused on the relation between the use
ofgarlic supplements and cancer. The effects of related foods
of the Allium genus, onion and leeks, will be studied as well,
because a negative association between other allium
vegetables and cancer has also been reported (Buiatti et al.,
1989; Steinmetz & Potter, 1991; You et al., 1988; You et al.,
1989).
In summary, evidence from laboratory experiments and
epidemiologic studies is not yet conclusive as to the preven-
tive capacity of garlic or garlic constituents. However, the
available evidence warrants further research into the possible
role of garlic in the prevention of cancer in humans.
Abbreviations: AFBI = aflatoxin BI; MNNG = N-methyl-N-nitro-N-
nitrosoguanidine; DMH = dimethylhydrazine; GST = glutathione
S-transferase; ODC = ornithine decarboxylase; TPA = tetradecanoyl-
phorbol-acetate; PMA = phorbol-myristate-acetate; BaP = benzo(a)-
pyrene; NDEA = N-nitrosodiethylamine; MNU = N-methylnitroso-
urea; DMNA = N-dimethylnitrosamine; MC = 3-methylcholanthrene;
NTP = S-nitro-2,4,6-triaminopyrimidine.
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